China Galaxy Securities Co., Ltd. Audit Report on the Termination of Partial Fund Investment Projects of Ruipu Bio-pharmaceutical Co., Ltd.
China Galaxy Securities Co., Ltd. (hereinafter referred to as "Galaxy Securities" or "Sponsor") is the sponsor of Ruipu Bio-pharmaceutical Co., Ltd. (hereinafter referred to as "Ruipu Bio-pharmaceutical" or "the Company") for its private placement of shares in 2021. In accordance with the "Administrative Measures for Securities Issuance and Listing Sponsorship Business (2025 Revision)", the "Shenzhen Stock Exchange Listed Company Self-regulatory Supervision Guidelines No. 13—Sponsorship Business", the "Shenzhen Stock Exchange GEM Stock Listing Rules (2025 Revision)", the "Shenzhen Stock Exchange Listed Company Self-regulatory Supervision Guidelines No. 2—Standardized Operation of GEM Listed Companies (2025 Revision)", and the "Supervision Rules for the Management of Raised Funds of Listed Companies", etc., Galaxy Securities has prudently audited the termination of some of the company's raised fund investment projects. The specific audit situation and opinions are as follows:
I. Basic Situation of Raised Funds
According to the "Reply on Agreeing to the Registration of Tianjin Ruipu Bio-pharmaceutical Technology Co., Ltd.'s Private Placement of Shares" (Securities Regulatory Permit (2021) No. 2974) issued by the China Securities Regulatory Commission, the company's application for registration of private placement of shares was approved. The company issued 63,984,674 ordinary shares of RMB ordinary shares (A shares) through private placement, with an issue price of RMB 20.88 per share. The total amount of raised funds was RMB 1,335,999,993.12. After deducting issuance expenses (excluding tax) of RMB 13,979,522.73, the net amount of raised funds was RMB 1,322,020,470.39.
On November 1, 2021, Lixin Certified Public Accountants (Special General Partnership) issued the "Capital Verification Report" (Xin Hui Shi Bao Zi [2021] No. ZG11889) for the receipt of raised funds from the company's private placement of shares, confirming the receipt of the raised funds. The company has deposited the above-mentioned raised funds in a special account for raised funds and signed the "Tripartite Supervision Agreement for Raised Funds" with the sponsor and the commercial bank where the raised funds are deposited.
II. Situation of Raised Fund Usage and Surplus
- Usage of Raised Funds
According to the "Prospectus for Private Placement of Shares (Registration Draft)", the "Announcement on Adjusting the Investment Amount of Raised Fund Investment Projects for Private Placement of Shares" (Announcement No.: 2021-158), and the "Announcement on Changing the Purpose of Some Raised Funds" (Announcement No.: 2025-076), the raised funds from the private placement of shares in this period are used for the following projects: